Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 2018243
PUBLISHER: Grand View Research | PRODUCT CODE: 2018243
Colorectal Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Diagnostic Kits & Assays, Instruments & Systems, Reagents & Consumables), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2026 - 2033
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Colorectal Cancer Diagnostics Market Summary
The global colorectal cancer diagnostics market size was estimated at USD 9.53 billion in 2025 and is projected to reach USD 14.39 billion by 2033, growing at a CAGR of 5.34% from 2026 to 2033. The industry is driven by the increasing incidence of colorectal cancer, rising demand for early and accurate diagnostic solutions, growing adoption of non-invasive screening methods, and advancements in molecular and genomic diagnostic technologies.
The rising prevalence of colorectal cancer, particularly among younger adults, is further increasing the need for effective screening and diagnostic approaches. In addition, the growing financial burden associated with colorectal cancer treatment is driving demand for more cost-effective and efficient diagnostic solutions. Technological advancements in genomics and molecular diagnostics are also improving the accuracy and personalization of colorectal cancer detection. Moreover, the increasing emphasis on early disease detection and preventive healthcare is encouraging the adoption of innovative colorectal cancer diagnostic technologies.
The global burden of colorectal cancer (CRC) continues to increase, making it among the most commonly diagnosed cancers worldwide. According to estimates from the International Agency for Research on Cancer (IARC) and the GLOBOCAN study published in Gut, approximately 1.9 million new CRC cases and over 930,000 deaths were reported globally in 2020. Projections indicate that the global burden could rise to around 3.2 million new cases and 1.6 million deaths annually by 2040. This increasing disease prevalence is a significant factor driving demand for improved screening, diagnostic, and treatment solutions. CRC is considered one of the most preventable cancers when detected early, particularly through the identification and removal of precancerous lesions. However, the growing incidence in transitioning economies and among younger adults highlights the need for improved awareness, preventive strategies, and broader screening initiatives to reduce future disease burden and mortality.
Early detection plays a critical role in improving survival outcomes, as colorectal cancer is highly treatable when diagnosed at an early stage. Timely diagnosis not only improves patient survival rates but also significantly reduces treatment costs compared to advanced-stage disease management. Consequently, the increasing emphasis on early detection is accelerating the adoption of advanced screening technologies. Non-invasive, at-home stool-based screening tests such as fecal immunochemical tests (FIT) and stool DNA tests (e.g., Cologuard) are gaining widespread acceptance due to their convenience and effectiveness, thereby improving patient compliance with screening programs. From an economic perspective, the treatment of late-stage colorectal cancer can cost up to three times more than early-stage treatment, strengthening the value of large-scale screening programs and preventive diagnostics.
Global Colorectal Cancer Diagnostic Market Report Segmentation
This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global colorectal cancer diagnostics market report on the basis of product, test type, cancer type, end-use, and region:
- Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Diagnostic Kits & Assays
- Instruments & Systems
- Reagent & Consumables
- Others
- Test Type Outlook (Revenue, USD Billion, 2021 - 2033)
- Stool-Based Tests
- Endoscopy-Based Tests
- Imaging Tests
- Blood-Based Tests
- Others
- Cancer Type Outlook (Revenue, USD Billion, 2021 - 2033)
- Adenocarcinoma
- Others
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Hospitals Laboratories
- Diagnostic Laboratories / Diagnostic Centers
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Academic Institutes
- Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Denmark
- Sweden
- Norway
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Rest of Middle East
Product Code: GVR-4-68040-877-4
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product Type
- 1.2.2. Product
- 1.2.3. Cancer Type
- 1.2.4. End-use
- 1.2.5. Regional Scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Colorectal Cancer Diagnostics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising global incidence of colorectal cancer
- 3.2.1.2. Government initiatives increasing public-health-awareness
- 3.2.1.3. Increasing awareness of early diagnostics
- 3.2.1.4. Innovation in genomics-rise in demand for noninvasive screening
- 3.2.1.5. Advancement in molecular diagnostics technological advancements next generation sequencing
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of advanced diagnostic procedures
- 3.2.2.2. Limited screening awareness in some regions
- 3.2.1. Market Driver Analysis
- 3.3. Colorectal Cancer Diagnostics Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. Colorectal Cancer Diagnostics Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Colorectal Cancer Diagnostics Market: Product Movement Analysis
- 4.3. Colorectal Cancer Diagnostics Market by Product Outlook (USD Billion)
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.5. Diagnostic Kits & Assays
- 4.5.1. Diagnostic Kits and Assays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Instruments & Systems
- 4.6.1. Instruments and Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Reagents & Consumables
- 4.7.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.8. Others
- 4.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Colorectal Cancer Diagnostics Market: Test Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Colorectal Cancer Diagnostics Market: Test Type Movement Analysis
- 5.3. Colorectal Cancer Diagnostics Market by Test Type Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.5. Stool-Based Tests
- 5.5.1. Stool-Based Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Endoscopy-Based Tests
- 5.6.1. Endoscopy-Based Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Imaging Tests
- 5.7.1. Imaging Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Blood-Based Tests
- 5.8.1. Blood Based Tests Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Other Tests
- 5.9.1. Other Tests Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Colorectal Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Colorectal Cancer Diagnostics Market: Cancer Type Movement Analysis
- 6.3. Colorectal Cancer Diagnostics Market by Cancer Type Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.5. Adenocarcinoma
- 6.5.1. Adenocarcinoma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Others
- 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Colorectal Cancer Diagnostics Market: End-use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Colorectal Cancer Diagnostics Market: End-use Movement Analysis
- 7.3. Colorectal Cancer Diagnostics Market by End-use Outlook (USD Million)
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 7.5. Hospital Laboratories
- 7.5.1. Hospital Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Diagnostic Laboratories / Diagnostic Centers
- 7.6.1. Diagnostic Laboratories / Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Cancer Research Institutes
- 7.7.1. Cancer Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Ambulatory Surgical Centers
- 7.8.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.9. Academic Institutes
- 7.9.1. Academic Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.10. Others
- 7.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Colorectal Cancer Diagnostics Market: Regional Estimates & Trend Analysis
- 8.1. Regional Dashboard
- 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 8.3. North America
- 8.3.1. U.S.
- 8.3.1.1. Key country dynamics
- 8.3.1.2. Regulatory framework/ reimbursement structure
- 8.3.1.3. Competitive scenario
- 8.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 8.3.2. Canada
- 8.3.2.1. Key country dynamics
- 8.3.2.2. Regulatory framework/ reimbursement structure
- 8.3.2.3. Competitive scenario
- 8.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.3.3. Mexico
- 8.3.3.1. Key country dynamics
- 8.3.3.2. Regulatory framework/ reimbursement structure
- 8.3.3.3. Competitive scenario
- 8.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
- 8.3.1. U.S.
- 8.4. Europe
- 8.4.1. UK
- 8.4.1.1. Key country dynamics
- 8.4.1.2. Regulatory framework/ reimbursement structure
- 8.4.1.3. Competitive scenario
- 8.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.2. Germany
- 8.4.2.1. Key country dynamics
- 8.4.2.2. Regulatory framework/ reimbursement structure
- 8.4.2.3. Competitive scenario
- 8.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.3. France
- 8.4.3.1. Key country dynamics
- 8.4.3.2. Regulatory framework/ reimbursement structure
- 8.4.3.3. Competitive scenario
- 8.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.4. Italy
- 8.4.4.1. Key country dynamics
- 8.4.4.2. Regulatory framework/ reimbursement structure
- 8.4.4.3. Competitive scenario
- 8.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.5. Spain
- 8.4.5.1. Key country dynamics
- 8.4.5.2. Regulatory framework/ reimbursement structure
- 8.4.5.3. Competitive scenario
- 8.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.6. Norway
- 8.4.6.1. Key country dynamics
- 8.4.6.2. Regulatory framework/ reimbursement structure
- 8.4.6.3. Competitive scenario
- 8.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.7. Sweden
- 8.4.7.1. Key country dynamics
- 8.4.7.2. Regulatory framework/ reimbursement structure
- 8.4.7.3. Competitive scenario
- 8.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Key country dynamics
- 8.4.8.2. Regulatory framework/ reimbursement structure
- 8.4.8.3. Competitive scenario
- 8.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.9. Rest of Europe
- 8.4.9.1. Key country dynamics
- 8.4.9.2. Regulatory framework/ reimbursement structure
- 8.4.9.3. Competitive scenario
- 8.4.9.4. Rest of Europe market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.1. UK
- 8.5. Asia Pacific
- 8.5.1. Japan
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework/ reimbursement structure
- 8.5.1.3. Competitive scenario
- 8.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2. China
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework/ reimbursement structure
- 8.5.2.3. Competitive scenario
- 8.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.3. India
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework/ reimbursement structure
- 8.5.3.3. Competitive scenario
- 8.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.4. Australia
- 8.5.4.1. Key country dynamics
- 8.5.4.2. Regulatory framework/ reimbursement structure
- 8.5.4.3. Competitive scenario
- 8.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key country dynamics
- 8.5.5.2. Regulatory framework/ reimbursement structure
- 8.5.5.3. Competitive scenario
- 8.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.6. Thailand
- 8.5.6.1. Key country dynamics
- 8.5.6.2. Regulatory framework/ reimbursement structure
- 8.5.6.3. Competitive scenario
- 8.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.7. Rest of Asia Pacific
- 8.5.7.1. Key country dynamics
- 8.5.7.2. Regulatory framework/ reimbursement structure
- 8.5.7.3. Competitive scenario
- 8.5.7.4. Rest of Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.1. Japan
- 8.6. Latin America
- 8.6.1. Brazil
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework/ reimbursement structure
- 8.6.1.3. Competitive scenario
- 8.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2. Argentina
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework/ reimbursement structure
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3. Rest of Latin America
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework/ reimbursement structure
- 8.6.3.3. Competitive scenario
- 8.6.3.4. Rest of Latin America market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.1. Brazil
- 8.7. MEA
- 8.7.1. South Africa
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework/ reimbursement structure
- 8.7.1.3. Competitive scenario
- 8.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2. Saudi Arabia
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework/ reimbursement structure
- 8.7.2.3. Competitive scenario
- 8.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.3. UAE
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework/ reimbursement structure
- 8.7.3.3. Competitive scenario
- 8.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.4. Kuwait
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework/ reimbursement structure
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.5. Rest of MEA
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Regulatory framework/ reimbursement structure
- 8.7.5.3. Competitive scenario
- 8.7.5.4. Rest of MEA market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.1. South Africa
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Recent Developments & Impact Analysis by Key Market Participants
- 9.3. Company Market Share Analysis, 2025
- 9.4. Key Company Profiles
- 9.4.1. Exact Sciences Corporation
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. F. Hoffmann-La Roche Ltd
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Abbott
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Danaher Corporation.
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Quest Diagnostics Incorporated.
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Fujifilm Holdings Corporation.
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. Olympus Corporation
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product benchmarking
- 9.4.7.4. Strategic initiatives
- 9.4.8. Epigenomics AG
- 9.4.8.1. Company overview
- 9.4.8.2. Financial performance
- 9.4.8.3. Product benchmarking
- 9.4.8.4. Strategic initiatives
- 9.4.9. Eiken Chemical Co., Ltd.
- 9.4.9.1. Company overview
- 9.4.9.2. Financial performance
- 9.4.9.3. Product benchmarking
- 9.4.9.4. Strategic initiatives
- 9.4.10. Guardant Health
- 9.4.10.1. Company overview
- 9.4.10.2. Financial performance
- 9.4.10.3. Product benchmarking
- 9.4.10.4. Strategic initiatives
- 9.4.1. Exact Sciences Corporation
Product Code: GVR-4-68040-877-4
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Global colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 4 Global colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 5 Global colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 6 Global colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 7 North America Colorectal Cancer Diagnostics market, by region, 2021 - 2033 (USD Million)
- Table 8 North America colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 9 North America colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 10 North America colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 11 North America colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 12 U.S. colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 13 U.S. colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 14 U.S. colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 15 U.S. colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 16 Canada colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 17 Canada colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 18 Canada colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 19 Canada colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 20 Mexico colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 21 Mexico colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 22 Mexico colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 23 Mexico colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 24 Europe colorectal cancer diagnostics market, by country, 2021 - 2033 (USD Million)
- Table 25 Europe colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 26 Europe colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 27 Europe colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 28 UK colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 29 UK colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 30 UK colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 31 UK colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 32 Germany colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 33 Germany colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 34 Germany colorectal cancer diagnostics market, by cancer type 2021 - 2033 (USD Million)
- Table 35 Germany colorectal cancer diagnostics market, by end use 2021 - 2033 (USD Million)
- Table 36 France colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 37 France colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 38 France colorectal cancer diagnostics market, by cancer type 2021 - 2033 (USD Million)
- Table 39 France colorectal cancer diagnostics market, by end use 2021 - 2033 (USD Million)
- Table 40 Italy colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 41 Italy colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 42 Italy colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 43 Italy colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 44 Spain colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 45 Spain colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 46 Spain colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 47 Spain colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 48 Denmark colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 49 Denmark colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 50 Denmark colorectal cancer diagnostics market, by cancer type 2021 - 2033 (USD Million)
- Table 51 Denmark colorectal cancer diagnostics market, by end use 2021 - 2033 (USD Million)
- Table 52 Sweden colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 53 Sweden colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 54 Sweden colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 55 Sweden colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 56 Norway colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 57 Norway colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 58 Norway colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 59 Norway colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 60 Rest of Europe colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 61 Rest of Europe colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 62 Rest of Europe colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 63 Rest of Europe colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 64 Asia Pacific colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 65 Asia Pacific colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 66 Asia Pacific colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 67 Asia Pacific colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 68 Japan colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 69 Japan colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 70 Japan colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 71 Japan colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 72 China colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 73 China colorectal cancer diagnostics market, by test type 2021 - 2033 (USD Million)
- Table 74 China colorectal cancer diagnostics market, by cancer type 2021 - 2033 (USD Million)
- Table 75 China colorectal cancer diagnostics market, by end use 2021 - 2033 (USD Million)
- Table 76 India colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 77 India colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 78 India colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 79 India colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 80 Australia colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 81 Australia colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 82 Australia colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 83 Australia colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 84 South Korea colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 85 South Korea colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 86 South Korea colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 87 South Korea colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 88 Thailand colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 89 Thailand colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 90 Thailand colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 91 Thailand colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 92 Rest of Asia Pacific colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 93 Rest of Asia Pacific colorectal cancer diagnostics market, test type, 2021 - 2033 (USD Million)
- Table 94 Rest of Asia Pacific colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 95 Rest of Asia Pacific colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 96 Latin America colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 97 Latin America colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 98 Latin America colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 99 Latin America colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 100 Brazil colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 101 Brazil colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 102 Brazil colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 103 Brazil colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 104 Argentina colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 105 Argentina colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 106 Argentina colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 107 Argentina colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 108 Rest of Latin America colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 109 Rest of Latin America colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 110 Rest of Latin America colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 111 Rest of Latin America colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 112 Middle East & Africa colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 113 Middle East & Africa colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 114 Middle East & Africa colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 115 Middle East & Africa colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 116 South Africa colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 117 South Africa colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 118 South Africa colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 119 South Africa colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 120 Saudi Arabia colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 121 Saudi Arabia colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 122 Saudi Arabia colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 123 Saudi Arabia colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million
- Table 124 UAE colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 125 UAE colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 126 UAE colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 127 UAE colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 128 Kuwait colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 129 Kuwait colorectal cancer diagnostics market, by test type, 2021 - 2033 (USD Million)
- Table 130 Kuwait colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 131 Kuwait colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
- Table 132 Rest of MEA colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 133 Rest of MEA colorectal cancer diagnostics market, by product, 2021 - 2033 (USD Million)
- Table 134 Rest of MEA colorectal cancer diagnostics market, by cancer type, 2021 - 2033 (USD Million)
- Table 135 Rest of MEA colorectal cancer diagnostics market, by end use, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 Information procurement
- Fig. 2 Primary research pattern
- Fig. 3 Market research approaches
- Fig. 4 Value chain-based sizing & forecasting
- Fig. 5 Market formulation & validation
- Fig. 6 Colorectal Cancer Diagnostics market segmentation
- Fig. 7 Market driver analysis (current & future impact)
- Fig. 8 Market restraint analysis (current & future impact)
- Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
- Fig. 10 Porter's five forces analysis
- Fig. 11 Colorectal Cancer Diagnostics market, product outlook key takeaways 2025 & 2033 (USD Million)
- Fig. 12 Colorectal Cancer Diagnostics market, product analysis 2025 & 2033 (USD Million)
- Fig. 13 Diagnostic kits & assays market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 14 Instruments & systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 15 Reagents & consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 16 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 17 Colorectal Cancer Diagnostics market, test type outlook key takeaways 2025 & 2033 (USD Million)
- Fig. 18 Colorectal Cancer Diagnostics market, test type analysis 2025 & 2033 (USD Million)
- Fig. 19 Stool-Based Tests market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 20 Endoscopy-Based Tests market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 21 Imaging Tests market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 22 Blood-Based Tests market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 23 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 24 Colorectal Cancer Diagnostics market, cancer type outlook key takeaways 2025 & 2033 (USD Million)
- Fig. 25 Colorectal Cancer Diagnostics market, cancer type analysis 2025 & 2033 (USD Million)
- Fig. 26 Adenocarcinoma market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 27 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 28 Colorectal Cancer Diagnostics market, end use outlook key takeaways 2025 & 2033 (USD Million)
- Fig. 29 Colorectal Cancer Diagnostics market, end use analysis 2025 & 2033 (USD Million)
- Fig. 30 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 31 Diagnostic Laboratories / Diagnostic Centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 32 Cancer Research Institutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 33 Ambulatory Surgical Centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 34 Academic Institutes revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 35 Others revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 36 North America colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 37 U.S. colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 38 Canada colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 39 Mexico colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 40 Europe colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 41 UK colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 42 Germany colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 43 France colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 44 Spain colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 45 Italy colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 46 Denmark colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 47 Sweden colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 48 Norway colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 49 Rest of Europe colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 50 Asia Pacific colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 51 China colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 52 Japan colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 53 India colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 54 South Korea colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 55 Australia colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 56 Thailand colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 57 Rest of Asia Pacific colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 58 Latin America colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 59 Brazil colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 60 Argentina colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 61 Rest of Latin America colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 62 Middle East and Africa colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 63 South Africa colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 64 Saudi Arabia colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 65 UAE colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 66 Kuwait colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 67 Rest of MEA colorectal cancer diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 68 List of key emerging company's
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.